N
NewsBrief
Business

Bausch Health Launches Solta Medical's Fraxel FTX in Australia

NewsBrief AI Editorial TeamPublished 1h ago
Bausch Health Launches Solta Medical's Fraxel FTX in Australia

Quick Brief

Bausch Health Companies Inc. and its aesthetics unit, Solta Medical, have announced the launch of the Fraxel FTX system in Australia. The next-generation skin resurfacing technology becomes accessible to healthcare practitioners in the country starting September 1, 2026.

What Happened?

Bausch Health Companies Inc. and its aesthetics business unit, Solta Medical, announced the commercial availability of the Fraxel FTX device for healthcare practitioners throughout Australia beginning September 1, 2026.

Why It Matters

The rollout introduces advanced skin resurfacing technology to the Australian aesthetic medical market, expanding the global footprint of Solta Medical's product offerings via its parent company Bausch Health.

Key Facts

  • Bausch Health Companies Inc. announced the availability of Solta Medical's Fraxel FTX.
  • The product is a next-generation skin resurfacing technology.
  • Availability in Australia begins on September 1, 2026.
  • Bausch Health trades on the NYSE and TSX under the ticker BHC.

Compiled from 1 outlet

Related Stories

NewsBrief
Business

US Treasury Chief Scott Bessent Faces Credibility Test Ahead of G20 Meeting in North Carolina

US Treasury Secretary Scott Bessent is encountering market skepticism following an interventionist summer ahead of the Group of 20 finance ministers gathering. He aims to refocus international discussions on boosting global economic growth. However, obstacles remain due to high energy prices from the conflict with Iran and newly launched US trade restrictions.

19min agoCompiled from 1 outlet